MwanzoCONCORDBIO • NSE
add
Concord Biotech Ltd
Bei iliyotangulia
₹ 2,066.55
Bei za siku
₹ 2,057.95 - ₹ 2,144.95
Bei za mwaka
₹ 1,327.05 - ₹ 2,664.00
Thamani ya kampuni katika soko
224.13B INR
Wastani wa hisa zilizouzwa
elfu 161.11
Uwiano wa bei na mapato
57.84
Mgao wa faida
0.41%
Ubadilishanaji wa msingi
NSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 3.10B | 18.23% |
Matumizi ya uendeshaji wa biashara | 1.10B | 6.68% |
Mapato halisi | 957.41M | 18.17% |
Kiwango cha faida halisi | 30.87 | -0.03% |
Mapato kwa kila hisa | 9.15 | 18.22% |
EBITDA | 1.37B | 14.74% |
Asilimia ya kodi ya mapato | 26.54% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.84B | 26.07% |
Jumla ya mali | 17.64B | 13.75% |
Jumla ya dhima | 1.74B | -11.57% |
Jumla ya hisa | 15.90B | — |
hisa zilizosalia | 104.63M | — |
Uwiano wa bei na thamani | 13.60 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 19.71% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 957.41M | 18.17% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
Ilianzishwa
2000
Tovuti
Wafanyakazi
1,377
